PitchBook-2023年二季度医学技术报告（英）-2023.8-12页_9mb

Summary of Medtech Report for Q2 2023

The report focuses on emerging technology in medical technology (medtech), covering key trends, investments, and opportunities from the second quarter of 2023. It is available through the PitchBook Platform and is confidential.

Q2 2023 showed slight increase in venture capital (VC) activity. Total VC funding reached $2.8 billion with 189 deals, up from Q1's $2.5 billion and 183 deals. This was a normalized level but still below the peak of $5.9 billion in Q2 2021. Notable deals include $150 million each for surgical robotics companies Distalmotion and Noah Medical. PE growth funding was lower at $54.5 million across 16 deals, with a decline in overall activity compared to last year.

Emerging opportunities highlight innovations in areas like mixed reality surgical navigation and solutions for sleep apnea. These advancements are driven by VC-backed startups aiming to accelerate development and market entry.

Company highlights include BillionToOne and AliveCor. AliveCor, a leader in personal ECG monitoring, raised $215.6 million total and has a high exit success score (98%) based on PitchBook data. It faces legal challenges with Apple over ECG patents.

The appendix provides data on top VC-backed medtech companies and investors, showing trends in funding, valuations, and deals.

Overall, the medtech sector saw moderate growth in VC funding and deals, with ongoing challenges in competition and exit opportunities.